Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
Summary
Oral presentation will include previously announced topline results as well as pre-specified and post-hoc data updates
Description
Oral presentation will include previously announced topline results as well as pre-specified and post-hoc data updates
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source